Blocking leptin‐STAT3 axis‐induced fatty acid oxidation: A novel approach to activate CD8+ T effector cells in breast cancer
Author:
Open Access
- 16 October 2020
- journal article
- editorial
- Published by Wiley in Thoracic Cancer
- Vol. 11 (12) , 3422-3424
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Immune precision medicine for cancer: a novel insight based on the efficiency of immune effector cellsCancer Communications, 2019
- Paradoxical effects of obesity on T cell function during tumor progression and PD-1 checkpoint blockadeNature Medicine, 2018
- When fats commit crimes: fatty acid metabolism, cancer stemness and therapeutic resistanceCancer Communications, 2018
- Lipid metabolism reprogramming and its potential targets in cancerCancer Communications, 2018
- Precision medicine becomes reality—tumor type‐agnostic therapyCancer Communications, 2018
- Immune evasion in cancer: Mechanistic basis and therapeutic strategiesSeminars in Cancer Biology, 2015
- CTLA4 aptamer delivers STAT3 siRNA to tumor-associated and malignant T cellsJournal of Clinical Investigation, 2015
- ER Stress Cooperates with Hypernutrition to Trigger TNF-Dependent Spontaneous HCC DevelopmentCancer Cell, 2014
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Targeting Stat3 in the Myeloid Compartment Drastically Improves the In vivo Antitumor Functions of Adoptively Transferred T CellsCancer Research, 2010